戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nalyzed a cohort of 22 patients with SLE and myelitis.
2 -IgG and its application to acute transverse myelitis.
3 e useful prognostic indicators in transverse myelitis.
4 n evolving understanding of acute transverse myelitis.
5 setting of a paraneoplastic acute transverse myelitis.
6 es in inflammatory non-infectious transverse myelitis.
7 rience with West Nile virus encephalitis and myelitis.
8  therapy of West Nile virus encephalitis and myelitis.
9 aracterized by attacks of optic neuritis and myelitis.
10  diagnosed as NMOSD or idiopathic transverse myelitis.
11 io-like neurological disorder, acute flaccid myelitis.
12      PE/IA may increase recovery in isolated myelitis.
13 me (GBS), meningoencephalitis, or transverse myelitis.
14  sporadically in patients with acute flaccid myelitis.
15  IFN signaling is protective during reovirus myelitis.
16 ), and other sub-acute syndromes (transverse myelitis (1), opsoclonus myoclonus (1)).
17  before we truly understand acute transverse myelitis: (1) What are the various triggers for the infl
18 eminated encephalomyelitis (12%), transverse myelitis (12%), and cerebellar ataxia (10%).
19 ations to be associated with ZIKV, including myelitis (4) , meningoencephalitis (5) and fatal encepha
20 h simultaneous/sequential optic neuritis and myelitis (44% vs 0%; P = .005).
21 tcomes than typical patients with transverse myelitis/acute disseminated encephalomyelitis, and these
22 ovirus D68 (EV-D68)-associated acute flaccid myelitis (AFM) is a devastating neurological disease for
23 /fall 2014, pediatric cases of acute flaccid myelitis (AFM) occurred in the United States, coincident
24 ent ON or recurrent longitudinally extensive myelitis alone are also often positive for AQP4-antibody
25  4 of 9 (44%) developed recurrent transverse myelitis and 1 of 9 (11%) developed optic neuritis (p =
26 equency of longitudinal extensive transverse myelitis and a favourable clinical outcome in contrast t
27                 One child with acute flaccid myelitis and a sibling with only upper respiratory illne
28 She then presented with recurrent transverse myelitis and a vesicobullous rash over her arms and feet
29                      Classically, transverse myelitis and acute disseminated encephalomyelitis are co
30 ching how we classify subtypes of transverse myelitis and acute disseminated encephalomyelitis.
31                                 Particularly myelitis and bilateral optic neuritis have poor remissio
32 a is a member of the Apicomplexa that causes myelitis and encephalitis in horses but normally cycles
33 assessed for neurologic variables related to myelitis and for clinical and serologic features of SLE.
34 hysterical paraplegia, the second transverse myelitis and its consequences for bladder function.
35 ysis, and was diagnosed as having transverse myelitis and membranous glomerulonephritis secondary to
36 s had initial CNS manifestations: transverse myelitis and meningoencephalitis.
37 uromyelitis optica spectrum disorder (NMOSD) myelitis and myelitis of other cause.
38 r anaphylaxis and death; 0.04 for transverse myelitis and pancreatitis; and 0.009 for motor neuron di
39 unopathogenic mechanisms in acute transverse myelitis and related inflammatory disorders of the spina
40 on between enterovirus D68 and acute flaccid myelitis and the contention that acute flaccid myelitis
41  by disabling relapses of optic neuritis and myelitis and the presence of aquaporin 4 antibodies (AQP
42 %) with encephalitis, 3 (8%) with transverse myelitis, and 1 (3%) with newly diagnosed chronic inflam
43 ute neuromuscular disease), 2 had transverse myelitis, and 1 had chronic inflammatory demyelinating p
44 of encephalopathy, encephalitis, meningitis, myelitis, and seizures have also been reported.
45 l retrograde to produce meningoencephalitis, myelitis, and stroke.
46 oses included multiple sclerosis, transverse myelitis, and unspecified neurodegenerative myelopathy.
47 who had relapsing optic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgia
48   Prognostic factors in pediatric transverse myelitis are reviewed.
49 ders associated with inflammatory transverse myelitis, as well as a greater appreciation of its diver
50             For example, in acute transverse myelitis associated with systemic disease (i.e. systemic
51                              To establish if myelitis-associated chronic pain in NMOSD is related to
52         Patients with isolated thoracic cord myelitis at the time of pain onset were significantly mo
53 as follows: (1) AQP4-IgG seropositivity, (2) myelitis attack and (3) MRI spinal cord demonstrating ri
54  with rLETM-onset NMO followed a median of 3 myelitis attacks (range, 2-19).
55 differences in the frequencies of transverse myelitis, brainstem involvement, cerebellar signs and se
56 nterovirus D68 with those with acute flaccid myelitis but negative for enterovirus D68 using the two-
57 D68 and the recent increase in acute flaccid myelitis cases in the United States.
58                                              Myelitis causes pain, weakness, and sphincteric deficits
59 ally and geographically linked acute flaccid myelitis clusters at the height of the 2014 outbreak, an
60 ncluding longitudinally extensive transverse myelitis), contributes to an evolving understanding of a
61  initial longitudinally extensive transverse myelitis, delay to diagnosis/treatment was greater when
62                 Optic neuritis or transverse myelitis developed after vomiting onset in 11 patients (
63 al fluid from 14 patients with acute flaccid myelitis did not reveal evidence of an alternative infec
64                             Short transverse myelitis does not exclude consideration of AQP4-IgG test
65  enterovirus D68 infection and acute flaccid myelitis during the 2014 enterovirus D68 respiratory out
66        Using experimental allergic encephalo myelitis (EAE), an animal model of multiple sclerosis, w
67               Our findings indicate that SLE myelitis encapsulates 2 distinct and previously unrecogn
68  1996 and 2015 with SCS or NMOSD whose first myelitis episode was accompanied by a spinal cord lesion
69 th an initial STM represented 14% of initial myelitis episodes among patients with NMOSD.
70 g-enhancement accompanies one-third of NMOSD myelitis episodes and distinguishes NMOSD from other cau
71 xial images in 36 of 43 (84%) ring enhancing myelitis episodes and extended a median of two vertebral
72 e clinical characteristics of ring-enhancing myelitis episodes did not differ from non-ring-enhancing
73 -enhancement was detected in 50 of 156 (32%) myelitis episodes in 41 patients (83% single; 17% multip
74   In AQP4-IgG-positive STM cases, subsequent myelitis episodes were longitudinally extensive in 92%.
75 nge, 1-12); in 21 of 48 (44%) ring enhancing myelitis episodes, the ring extended greater than or equ
76 erintensity in 44 of 50 (88%) ring enhancing myelitis episodes.
77  D68 sequences associated with acute flaccid myelitis grouped into a clade B1 strain that emerged in
78  biomarkers associated with acute transverse myelitis has led to a better understanding of the spectr
79                                    Radiation myelitis has long been recognised as a sinister conseque
80    For the last century, descriptions of SLE myelitis have been primarily limited to case reports.
81                             Acute transverse myelitis in children, in contrast to adults, is more lik
82 neurologic toxicity consisting of transverse myelitis in five patients, CNS toxicity in three, and se
83 he central nervous system; necrotizing focal myelitis in the cervical spinal cord; radiculitis; neuri
84 ive myelopathy of other cause (n=66) and (2) myelitis in the context of a concurrent or subsequent di
85 stigate innate immune responses during viral myelitis, including the activation of glia (microglia an
86                             Acute transverse myelitis is a group of disorders characterized by focal
87                             Acute transverse myelitis is a pathogenetically heterogeneous inflammator
88 elitis and the contention that acute flaccid myelitis is a rare yet severe clinical manifestation of
89                             Short transverse myelitis is not uncommon in NMOSD and, when it is presen
90 nts with longitudinally extensive transverse myelitis (LETM) behave differently from those with AQP4-
91          Longitudinally extensive transverse myelitis (LETM) is a frequently devastating clinical syn
92 ation of longitudinally extensive transverse myelitis (LETM) predicts relapse of myelitis or developm
93 a (NMO), longitudinally extensive transverse myelitis (LETM), multiple sclerosis with a history of op
94                             Acute transverse myelitis may be an isolated entity or may occur in the c
95 ay be complicated by postherpetic neuralgia, myelitis, meningoencephalitis, and VZV vasculopathy.
96 uded radiation recall (n = 2) and transverse myelitis (n = 1).
97  (NMOSD, n=10), idiopathic AQP4-IgG-negative myelitis (n=4), idiopathic AQP4-IgG-negative optic neuri
98 4), and other subacute syndromes (transverse myelitis [n = 1], opsoclonus myoclonus [n = 1]).
99        In many recurrent cases who also have myelitis (neuromyelitis optica) a serum antibody to aqua
100 nded fever, seizure, meningitis/encephalitis/myelitis, nonanaphylactic serious allergic reaction, ana
101 e flaccid paralysis associated with anterior myelitis noted in the United States from 2012 to 2015.
102 rger-scale cohort studies have revealed that myelitis occurring in the idiopathic demyelinating disea
103 ptica spectrum disorder (NMOSD) myelitis and myelitis of other cause.
104 ansverse myelitis (LETM) predicts relapse of myelitis or development of optic neuritis.
105                                No transverse myelitis or late toxicities of grade 4 or greater have b
106 lomyelitis (ADEM), one episode of transverse myelitis or optic neuritis, multiple sclerosis (MS), ant
107  weakness and sensory loss due to transverse myelitis or peripheral nerve disease.
108 s ratio [OR] = 0.97, p = 0.011), presence of myelitis (OR = 0.38, p = 0.002), CR from previous attack
109 event (optic neuritis, incomplete transverse myelitis, or brain-stem or cerebellar syndrome) and evid
110 ation (optic neuritis, incomplete transverse myelitis, or brain-stem/cerebellar syndrome) and at leas
111  in the diagnosis of any acute encephalitis, myelitis, or encephalomyelitis.
112 syndromes such as optic neuritis, transverse myelitis, or isolated brainstem syndromes in whom multif
113 m 12 (48%) of 25 patients with acute flaccid myelitis overall.
114  for isolated optic neuritis versus isolated myelitis (p < 0.001), and for unilateral versus bilatera
115 sed by a longitudinally extensive transverse myelitis (p=0.003), more often a complete resolution of
116                                        NMOSD myelitis patients were more commonly women, had concurre
117 cephalopathy, optic papillitis, inflammatory myelitis, postural tremor, and cerebellar ataxia.
118 ratory illness in children and acute flaccid myelitis, raising concerns about its potential impact on
119                                Acute flaccid myelitis refers to acute flaccid limb weakness with spin
120 total lesion burden and number of transverse myelitis relapses did not correlate with pain.
121 ronic pain scores, irrespective of number of myelitis relapses, lesion length and lesion burden.
122 1.4 per month, and admissions for transverse myelitis remained constant at 0.6 per month.
123 itis and longitudinally extensive transverse myelitis [reported on at least 1 magnetic resonance imag
124                                     Isolated myelitis responded better to PE/IA than to HD-S as first
125 f a spinal cord biopsy during ring-enhancing myelitis revealed tissue vacuolation and loss of AQP4 im
126 ecurrent longitudinally extensive transverse myelitis (rLETM) are lacking.
127 ially presented with 2 attacks of transverse myelitis (rLETM-onset NMO).
128 tudy was undertaken to determine whether SLE myelitis similarly encapsulates distinct syndromes.
129                             Short transverse myelitis (STM; <3 vertebral segments) is considered nonc
130 cidated about the causes of acute transverse myelitis, tantalizing clues as to the potential immunopa
131 rteriovenous fistula is a very rare cause of myelitis that can only be treated interventionally or su
132 recognized cause of longitudinally extensive myelitis that commonly mimics NMOSD.
133               In idiopathic acute transverse myelitis, there is an intraparenchymal or perivascular c
134 tis (ADEM), two with ON, one with transverse myelitis (TM) and two with clinically isolated syndrome
135 sent with optic neuritis (ON) and transverse myelitis (TM) are diagnosed with NMO and those who show
136                                   Transverse myelitis (TM) is an immune-mediated spinal cord disorder
137 ggested that vaccines may trigger transverse myelitis (TM) or acute disseminated encephalomyelitis (A
138 syndromes (CIS), 27 patients with transverse myelitis (TM), 50 patients with human immunodeficiency v
139 by severe optic neuritis (ON) and transverse myelitis (TM).
140 ritis (ON); 20% bilateral ON; 15% transverse myelitis (TM); 15% simultaneous TM&ON; 10% Acute dissemi
141 atients were included: 25 with acute flaccid myelitis, two with enterovirus-associated encephalitis,
142                                              Myelitis usually is known to respond well to immunosuppr
143                                     Reovirus myelitis was associated with the pronounced activation o
144                                   Transverse myelitis was the initial diagnosis.
145  initial longitudinally extensive transverse myelitis were excluded (n = 151).
146                  Patients with acute flaccid myelitis who presented to two hospitals in Colorado and
147      We compared patients with acute flaccid myelitis who were positive for enterovirus D68 with thos
148 on-multiple sclerosis optic neuritis without myelitis will be shown to be associated with this autoan
149 uromyelitis optica spectrum disorder (NMOSD) myelitis, with no satisfactory treatment; few studies ha

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top